INZY(Delisted)
Inozyme PharmaยทNASDAQ
--
--(--)
INZY Profile
Inozyme Pharma, Inc.
A clinical-stage rare disease biopharmaceutical company developing novel therapeutics for the treatment of abnormal mineralization
321 Summer Street, Suite 400, Boston, Massachusetts 02210
--
Inozyme Pharma, Inc., was established in September 2015 under the laws of the State of Delaware. The company is a rare disease biopharmaceutical company focused on developing novel therapies to treat abnormal mineralized diseases affecting blood vessels, soft tissues and bones. With a deep understanding of the biological pathways involved in mineralization, the company is committed to developing therapeutic agents to address the root causes of these debilitating diseases.
